Barinder Singh
Mohali, HR, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Identifying Minimum Threshold Level of Trial Crossover Rates Yielding Nonsignificant Overall Survival Benefit Associated with Cancer Treatments: A Systematic Literature Review of HTA Submissions.
Journal: Journal of health economics and outcomes research
Published: March 23, 2026
Cost-effectiveness modeling of mortality risk reduction comparing two fixed-dose combination triple therapies in moderate-to-very severe chronic obstructive pulmonary disease.
Journal: Journal of comparative effectiveness research
Published: December 15, 2025
Efficacy of sacituzumab govitecan versus treatment of physician's choice in previously treated HR+ and HER2- mBC: a meta-analysis of TROPiCS-02 and EVER-132-002 trials.
Journal: Therapeutic advances in medical oncology
Published: November 13, 2024
Mortality risk reduction with budesonide/glycopyrrolate/formoterol fumarate versus fluticasone furoate/umeclidinium/vilanterol in COPD: a matching-adjusted indirect comparison based on ETHOS and IMPACT.
Journal: Current medical research and opinion
Published: August 16, 2023
Letter to the Editor Regarding "Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Triple Therapy Compared with Other Therapies for the Treatment of COPD: A Network Meta-Analysis".
Journal: Advances in therapy
Published: November 15, 2022
Prognostic risk factors for moderate-to-severe exacerbations in patients with chronic obstructive pulmonary disease: a systematic literature review.
Journal: Respiratory research
Published: March 02, 2022
Diagnostic and economic value of biomarker testing for targetable mutations in non-small-cell lung cancer: a literature review.
Journal: Future oncology (London, England)
Published: December 06, 2021
Efficacy and Safety of Budesonide/Glycopyrronium/Formoterol Fumarate versus Other Triple Combinations in COPD: A Systematic Literature Review and Network Meta-analysis.
Journal: Advances in therapy
Published: January 22, 2021
A Systematic Literature Review of the Humanistic Burden of COPD.
Journal: International journal of chronic obstructive pulmonary disease
Published: December 15, 2020
Use of rituximab in adults with relapsing-remitting multiple sclerosis: a systematic literature review.
Journal: Current medical research and opinion
Published: March 05, 2020
Efficacy of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Versus Other Inhaled Corticosteroid/Long-Acting Muscarinic Antagonist/Long-Acting β2-Agonist (ICS/LAMA/LABA) Triple Combinations in COPD: A Systematic Literature Review and Network Meta-analysis.
Journal: Advances in therapy
Published: February 10, 2020
Protective effect of losartan and ramipril against stress induced insulin resistance and related complications: Anti-inflammatory mechanisms.
Journal: European journal of pharmacology
Published: January 18, 2017
Last Updated: 09/26/2026